Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

    • Autoimmune Disorder
    • Juvenile Idiopathic Arthritis